The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium
Justin M. Balko(Vanderbilt University Medical Center), Rebecca S. Cook(Vanderbilt University), David Jee(Kettering University), Violeta Sánchez(Vanderbilt University), Carlos L. Arteaga(The University of Texas Southwestern Medical Center), Christian D. Young(Raptamer Discovery Group (United States)), Charles M. Perou(University of North Carolina at Chapel Hill), Todd W. Miller(Dartmouth College), Katherine E. Hutchinson(Vanderbilt University), Aleix Prat(Hospital Clínic de Barcelona), Meghan M. Morrison(Vanderbilt University), Cammie Rinehart(Vanderbilt University), Kornélia Polyák(Dana-Farber Cancer Institute)
Cited by 75
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k